Most lately, it's been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some wide array of endogenous opioids. Unlike most opioid receptors, this receptor acts to be a scavenger https://alanm752hij3.blogmazing.com/profile